Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as $22.28 and last traded at $22.28, with a volume of 6414 shares changing hands. The stock had previously closed at $20.20.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. assumed coverage on shares of Ascentage Pharma Group International in a research report on Thursday, March 27th. They set an "overweight" rating on the stock.
View Our Latest Research Report on Ascentage Pharma Group International
Ascentage Pharma Group International Trading Up 3.5 %
Ascentage Pharma Group International Company Profile
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
